Skip to main content
. Author manuscript; available in PMC: 2009 Nov 3.
Published in final edited form as: N Engl J Med. 1981 Jul 30;305(5):266–269. doi: 10.1056/NEJM198107303050507

Table 2.

Current Liver Function and Maintenance Therapy in 10 Patients.

Patient No. Age/Sex Time after Surgery Current Liver Function Serum Creatinine Maintenance Therapy
Serum Bilirubin Alkaline Phophatase Sgot* Cyclosporin Prednisone
mo mg/dl (μmol/liter units/liter mg/dl (mmol/liter) mg/kg/day mg/day
1 28/F 14½ 1.2 (20.5) 155 21 1.6 (141) 7.9 20
2 25/M 14½ 1.3 (22.2) 477 48 1.8 (159) 5.1 15
3 37/F 14 0.5 (8.6) 136 35 1.0 (88) 9.5 10
4 20/F 14 2.2 (37.6) 55 10 4.6 (407) 5.1 5
5 41/F 13½ 0.3 (5.1) 332 93 1.3 (115) 9.1 10
7 26/M 12½ 1.2 (20.5) 141 38 2.0 (177) 9.8 10
8 21/F 12 1.1 (18.8) 52 26 1.0 (88) 6.8 15
9 16/F 9 1.7 (29.1) 151 49 1.3 (115) 9.8 10
10 28/F 9 2.4 (41.0) 220 67 1.6 (141) 7.7 12.5
12 10/F 8 0.8 (13.7) 863 39 0.5 (44) 7.1 10
*

Serum aspartate aminotransferase.

This patient has recurrent Budd–Chiari syndrome with secondary renal dysfunction.